Bliss GVS Pharma granted 180,000 stock options to eligible employees under its 2019 ESOP plan.
The options have an exercise price of ₹43 per share, set at an 84.20% discount to the market price.
Vesting occurs in four equal annual instalments over 48 months, with a six-month exercise window post-vesting.
This is a regulatory disclosure made pursuant to SEBI Listing Obligations and Disclosure Requirements.